000 01410 a2200385 4500
005 20250513150145.0
264 0 _c19980807
008 199808s 0 0 eng d
022 _a0344-5704
024 7 _a10.1007/s002800050810
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGhielmini, M
245 0 0 _aHematotoxicity on human bone marrow- and umbilical cord blood-derived progenitor cells and in vitro therapeutic index of methoxymorpholinyldoxorubicin and its metabolites.
_h[electronic resource]
260 _bCancer chemotherapy and pharmacology
_c1998
300 _a235-40 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntibiotics, Antineoplastic
_xadverse effects
650 0 4 _aBone Marrow
_xdrug effects
650 0 4 _aDoxorubicin
_xadverse effects
650 0 4 _aFetal Blood
_xdrug effects
650 0 4 _aHumans
650 0 4 _aStem Cells
_xdrug effects
650 0 4 _aTumor Cells, Cultured
_xdrug effects
650 0 4 _aTumor Stem Cell Assay
700 1 _aColli, E
700 1 _aBosshard, G
700 1 _aPennella, G
700 1 _aGeroni, C
700 1 _aTorri, V
700 1 _aD'Incalci, M
700 1 _aCavalli, F
700 1 _aSessa, C
773 0 _tCancer chemotherapy and pharmacology
_gvol. 42
_gno. 3
_gp. 235-40
856 4 0 _uhttps://doi.org/10.1007/s002800050810
_zAvailable from publisher's website
999 _c9650784
_d9650784